Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis.

Jiang M, Wu N, Xu B, Chu Y, Li X, Su S, Chen D, Li W, Shi Y, Gao X, Zhang H, Zhang Z, Du W, Nie Y, Liang J, Fan D.

Theranostics. 2019 Jul 9;9(18):5359-5373. doi: 10.7150/thno.34024. eCollection 2019.

2.

CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway.

Pan J, Fan Z, Wang Z, Dai Q, Xiang Z, Yuan F, Yan M, Zhu Z, Liu B, Li C.

J Exp Clin Cancer Res. 2019 Feb 4;38(1):52. doi: 10.1186/s13046-019-1049-7.

3.

O-GlcNAcylation of NF-κB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression.

Ali A, Kim SH, Kim MJ, Choi MY, Kang SS, Cho GJ, Kim YS, Choi JY, Choi WS.

Mol Cells. 2017 Jul 31;40(7):476-484. doi: 10.14348/molcells.2017.2309. Epub 2017 Jul 6.

4.

Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming.

Tan Y, Lin K, Zhao Y, Wu Q, Chen D, Wang J, Liang Y, Li J, Hu J, Wang H, Liu Y, Zhang S, He W, Huang Q, Hu X, Yao Z, Liang B, Liao W, Shi M.

Theranostics. 2018 Oct 29;8(19):5452-5468. doi: 10.7150/thno.28219. eCollection 2018.

5.

Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.

Jiang M, Qiu Z, Zhang S, Fan X, Cai X, Xu B, Li X, Zhou J, Zhang X, Chu Y, Wang W, Liang J, Horvath T, Yang X, Wu K, Nie Y, Fan D.

Oncotarget. 2016 Sep 20;7(38):61390-61402. doi: 10.18632/oncotarget.11359.

6.

OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.

Zhang D, Cai Y, Chen M, Gao L, Shen Y, Huang Z.

Inflamm Res. 2015 Dec;64(12):943-52. doi: 10.1007/s00011-015-0877-y. Epub 2015 Sep 25.

PMID:
26407569
7.

O-GlcNAcylation is associated with the development and progression of gastric carcinoma.

Jang TJ, Kim UJ.

Pathol Res Pract. 2016 Jul;212(7):622-30. doi: 10.1016/j.prp.2016.04.002. Epub 2016 Apr 14.

PMID:
27131860
8.

Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.

Ma Z, Vocadlo DJ, Vosseller K.

J Biol Chem. 2013 May 24;288(21):15121-30. doi: 10.1074/jbc.M113.470047. Epub 2013 Apr 16.

9.

Fatty-acid receptor CD36 functions as a hydrogen sulfide-targeted receptor with its Cys333-Cys272 disulfide bond serving as a specific molecular switch to accelerate gastric cancer metastasis.

Wang R, Tao B, Fan Q, Wang S, Chen L, Zhang J, Hao Y, Dong S, Wang Z, Wang W, Cai Y, Li X, Bao T, Wang X, Qiu X, Wang K, Mo X, Kang Y, Wang Z.

EBioMedicine. 2019 Jul;45:108-123. doi: 10.1016/j.ebiom.2019.06.037. Epub 2019 Jun 28.

10.

Consumption of a high fat diet promotes protein O-GlcNAcylation in mouse retina via NR4A1-dependent GFAT2 expression.

Dai W, Dierschke SK, Toro AL, Dennis MD.

Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3568-3576. doi: 10.1016/j.bbadis.2018.09.006. Epub 2018 Sep 11.

PMID:
30254013
11.

Thiamine attenuates the hypertension and metabolic abnormalities in CD36-defective SHR: uncoupling of glucose oxidation from cellular entry accompanied with enhanced protein O-GlcNAcylation in CD36 deficiency.

Tanaka T, Sohmiya K, Kono T, Terasaki F, Horie R, Ohkaru Y, Muramatsu M, Takai S, Miyazaki M, Kitaura Y.

Mol Cell Biochem. 2007 May;299(1-2):23-35.

PMID:
16645728
12.

Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.

Laczy B, Fülöp N, Onay-Besikci A, Des Rosiers C, Chatham JC.

PLoS One. 2011 Apr 11;6(4):e18417. doi: 10.1371/journal.pone.0018417.

13.

Hyper-O-GlcNAcylation activates nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signaling through interplay with phosphorylation and acetylation.

Ma Z, Chalkley RJ, Vosseller K.

J Biol Chem. 2017 Jun 2;292(22):9150-9163. doi: 10.1074/jbc.M116.766568. Epub 2017 Apr 17.

14.

O-GlcNAcylation of the Signaling Scaffold Protein, GNB2L1 Promotes its Degradation and Increases Metastasis of Gastric Tumours.

Cheng S, Ren J, Su L, Liu J, Liu Q, Zhou J, Ye X, Zhu N.

Biochem Biophys Res Commun. 2016 Sep 30;478(4):1497-502. doi: 10.1016/j.bbrc.2016.08.074. Epub 2016 Aug 13.

PMID:
27530921
15.

Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway.

Pan J, Dai Q, Zhang T, Li C.

Cancer Cell Int. 2019 Mar 22;19:69. doi: 10.1186/s12935-019-0787-0. eCollection 2019.

16.

Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.

Ladanyi A, Mukherjee A, Kenny HA, Johnson A, Mitra AK, Sundaresan S, Nieman KM, Pascual G, Benitah SA, Montag A, Yamada SD, Abumrad NA, Lengyel E.

Oncogene. 2018 Apr;37(17):2285-2301. doi: 10.1038/s41388-017-0093-z. Epub 2018 Feb 5.

17.

Augmented TME O-GlcNAcylation Promotes Tumor Proliferation through the Inhibition of p38 MAPK.

Moriwaki K, Asahi M.

Mol Cancer Res. 2017 Sep;15(9):1287-1298. doi: 10.1158/1541-7786.MCR-16-0499. Epub 2017 May 23.

18.

Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.

Zhang N, Chen X.

Biotechnol Appl Biochem. 2016 Nov;63(6):841-851. doi: 10.1002/bab.1441. Epub 2015 Nov 23.

PMID:
26333304
19.

MicroRNA-7 as a potential therapeutic target for aberrant NF-κB-driven distant metastasis of gastric cancer.

Ye T, Yang M, Huang D, Wang X, Xue B, Tian N, Xu X, Bao L, Hu H, Lv T, Huang Y.

J Exp Clin Cancer Res. 2019 Feb 6;38(1):55. doi: 10.1186/s13046-019-1074-6.

20.

Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.

Wang L, Chen S, Zhang Z, Zhang J, Mao S, Zheng J, Xuan Y, Liu M, Cai K, Zhang W, Guo Y, Zhai W, Yao X.

BMC Cancer. 2018 Nov 20;18(1):1141. doi: 10.1186/s12885-018-5033-y.

Supplemental Content

Support Center